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ABSTRACT

Protein tyrosine phosphatase 1B (PTP1B) is an abundant mammalian enzyme present ubiquitously in the
cell. PTP1B has been characterized as a central player in the insulin and leptin signaling pathways. 
Peracetic acid is a strong oxidant molecule produced by several bacterial hydrolase, perhydrolase,
haloperoxidase, lipase enzyme and few mammalian decarboxylase enzymes. Here we presented the
evidence that peracetic acid and other organic peroxide can reversibly inactivate the PTPs function in low
nanomolar concentration and that the inactivation is potent in presence of cellular reducing agent,
glutathione. The result shows that peracetic acid posses the characteristic of ROS and other cell signaling
messengers like H2O2 to survive inside the cell under reducing condition. The condition how peracetic acid
is produced inside the cell is not yet known. Our study shows that peracetic acid has the potential to
regulate the PTPase function and indicate that peracetic acid might act as a third messenger or secondary
oxidant in insulin signaling pathways if generated during that time frame. Lipid peroxide (13S)-
hydroperoxyoctadecanoic acid (13S-HPODE) which is a dietary metabolite is known to prolong the
phosphorylaion of endothelial growth factor (EGF). Our in vitro study demonstrates that 13S-HPODE can
inhibit the PTPase function in an identical manner as H2O2 and could be the probable mechanism for
increased EGF phosphorylation. 
Oltipraz is a cancer preventive agent which is currently undergoing clinical phase trial II. Oltipraz triggers its
chemo preventive action by the inducing of cell protecting enzymes, generally known as phase II enzyme
by interacting with keap-Nrf2 pathways. Keap1 is a redox sensitive enzyme and it can interact with
electrophile like oltipraz. Oltipraz also causes activation of ERK pathways, NF-ÎºB transcription factor and
several other important biological pathways. We are the first to establish that oltipraz inhibits PTPs function
like other cys-dependent proteins by reversible chemical modification. Two distinct studies show that PTPs
inhibition and oltipraz, both individually can lead to the activation of NF-ÎºB. Our study raises the possibility
that oltipraz mediated PTPs inhibition might have the potential to trigger the NF-ÎºB activation. 
Hydrogen sulfide signaling has started getting attention in various aspects of cellular disease and
therapeutics. H2S can cause upregulation of various kinase phosphorylation pathways such as Akt in case
of pro-angiogenesis. Mechanism for many of the H2S mediated signaling pathways is not yet known.  Our
preliminary study shows that H2S metabolite sulfate (SO32-) can individually and by combination with other
reactive oxygen species inactivate the PTPase function. Characterization of those combined species yet
need to be determined. Our work implicates the importance of metabolism of endogenous H2S relevant to
PTPase function during cell signaling. 
